
### [MONDO:0007108](http://purl.obolibrary.org/obo/MONDO_0007108)
**Label:** anal canal carcinoma

**Subclasses:** [MONDO:0002735](http://purl.obolibrary.org/obo/MONDO_0002735) (anal canal adenocarcinoma (disease)), 

**Corr. equiv. classes:** [Orphanet:424016](http://www.orpha.net/ORDO/Orphanet_424016), 

**Class expressions from DL-Learner:**

- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0100834](http://purl.obolibrary.org/obo/HP_0100834) (Neoplasm of the large intestine) 100.00%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 100.00%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0100606](http://purl.obolibrary.org/obo/HP_0100606) (Neoplasm of the respiratory system) 100.00%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0100526](http://purl.obolibrary.org/obo/HP_0100526) (Neoplasm of the lung) 100.00%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0030437](http://purl.obolibrary.org/obo/HP_0030437) (Anal canal neoplasm) 100.00%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 100.00%
- [HP:0010622](http://purl.obolibrary.org/obo/HP_0010622) (Neoplasm of the skeletal system) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 100.00%
- [HP:0007378](http://purl.obolibrary.org/obo/HP_0007378) (Neoplasm of the gastrointestinal tract) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 100.00%
- [HP:0006749](http://purl.obolibrary.org/obo/HP_0006749) (Malignant gastrointestinal tract tumors) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 100.00%
- [HP:0002896](http://purl.obolibrary.org/obo/HP_0002896) (Neoplasm of the liver) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 100.00%
- [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 100.00%
- [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 100.00%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 100.00%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 100.00%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 100.00%


